Evasion of Type I Interferon by SARS-CoV-2

Xia, Hongjie, Cao, Zengguo, Xie, Xuping, Zhang, Xianwen, Chen, John Yun-Chung, Wang, Hualei, Menachery, Vineet D., Rajsbaum, Ricardo +1 more·2020·Cell Reports
DOI 10.1016/j.celrep.2020.108234

Cited by (958)

Items 101–200 of 958

  1. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence
    Xianwen Zhang, Yang Liu, Jianying Liu, Adam L. Bailey, Kenneth S. Plante, Jessica A. Plante, Jing Zou, Hongjie Xia, Nathen E. Bopp, Patricia V. Aguilar et al. · 2021 · Cell
  2. Sarbecovirus ORF6 proteins hamper induction of interferon signaling
    Izumi Kimura, Yoriyuki Konno, Keiya Uriu, Kristina Hopfensperger, Daniel Sauter, So Nakagawa, Kei Sato · 2021 · Cell Reports
  3. Coronaviruses exploit a host cysteine-aspartic protease for replication
    Hin Chu, Yuxin Hou, Dong Yang, Lei Wen, Huiping Shuai, Chaemin Yoon, Jialu Shi, Yue Chai, Terrence Tsz‐Tai Yuen, Bingjie Hu et al. · 2022 · Nature
  4. Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract
    Or Alfi, Arkadi Yakirevitch, Ori Wald, Ori Wandel, Uzi Izhar, Esther Oiknine‐Djian, Yuval Nevo, Sharona Elgavish, Elad Dagan, Ory Madgar et al. · 2021 · Journal of Virology
  5. Replication and single-cycle delivery of SARS-CoV-2 replicons
    Inna Ricardo-Lax, Joseph M. Luna, Tran Thi Nhu Thao, Jérémie Le Pen, Yingpu Yu, Hans-Heinrich Hoffmann, William M. Schneider, Brandon S. Razooky, Javier Fernández-Martı́nez, Fabian Schmidt et al. · 2021 · Science
  6. BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2
    Avi J. Samelson, Quang Dinh Tran, Rémy Robinot, Lucía Carrau, Veronica V. Rezelj, Alice Mac Kain, Merissa Chen, Gokul N. Ramadoss, Xiaoyan Guo, Shion An Lim et al. · 2022 · Nature Cell Biology
  7. The influenza virus PB2 protein evades antiviral innate immunity by inhibiting JAK1/STAT signalling
    Hui Min Yang, Yurui Dong, Ying Bian, Nuo Xu, Yuwei Wu, Fan Yang, Yinping Du, Tao Qin, Sujuan Chen, Daxin Peng et al. · 2022 · Nature Communications
  8. Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression
    Keisuke Nakagawa, Shinji Makino · 2021 · Cells
  9. Endomembrane targeting of human OAS1 p46 augments antiviral activity
    Frank W. Soveg, Johannes Schwerk, Nandan S. Gokhale, Karen M. Cerosaletti, Julian R. Smith, Erola Pairo‐Castineira, Alison M. Kell, Adriana Forero, Shivam A. Zaver, Katharina Esser‐Nobis et al. · 2021 · eLife
  10. Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape
    Jonathan C. Brown, Daniel H. Goldhill, Jie Zhou, Thomas P. Peacock, Rebecca Frise, Niluka Goonawardane, Laury Baillon, Ruthiran Kugathasan, Andreia Pinto, Paul F. McKay et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  11. The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies
    Shilei Zhang, Lulan Wang, Genhong Cheng · 2022 · Molecular Therapy
  12. SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression
    Artem A. Nemudryi, Anna Nemudraia, Tanner Wiegand, Joseph E. Nichols, Deann Teresa Snyder, Jodi F. Hedges, Calvin Cicha, Helen Lee, Karl K. Vanderwood, Diane Bimczok et al. · 2021 · Cell Reports
  13. Type I interferons and SARS-CoV-2: from cells to organisms
    P. Bastard, Qian Zhang, Shen-Ying Zhang, E. Jouanguy, J. Casanova · 2022 · Current Opinion in Immunology
  14. Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
    Hao Zhou, Michelle Møhlenberg, Jigarji Chaturji Thakor, Hardeep Singh Tuli, Pengfei Wang, Yehuda G. Assaraf, Kuldeep Dhama, Shibo Jiang · 2022 · Clinical Microbiology Reviews
  15. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3
    Sin‐Yee Fung, Kam‐Leung Siu, Huayue Lin, Man Lung Yeung, Dong‐Yan Jin · 2021 · International Journal of Biological Sciences
  16. Coronavirus Nsp1: Immune Response Suppression and Protein Expression Inhibition
    Shuai Yuan, Shravani Balaji, Ivan B. Lomakin, Yong Xiong · 2021 · Frontiers in Microbiology
  17. A scoping review of the pathophysiology of COVID-19
    Paul Ellis Marik, Jose I. Iglesias, Joseph Varón, Pierre D. Kory · 2021 · International Journal of Immunopathology and Pharmacology
  18. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
    Mahdi Eskandarian Boroujeni, Agata Sekrecka, Aleksandra Antonczyk, Sanaz Hassani, Michał Sekrecki, Hanna Nowicka, Natalia Łopacinska, Arta Olya, Katarzyna Kluzek, Joanna Wesoły et al. · 2022 · Frontiers in Immunology
  19. SARS-CoV-2: A Master of Immune Evasion
    Alberto Rubio‐Casillas, Elrashdy M Moustafa Mohamed Redwan, Vladimir Nikolaevich Uversky · 2022 · Biomedicines
  20. Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase III POETYK trials
    Mark Lebwohl, Richard Bruce Warren, Howard L. Sofen, Shinichi Imafuku, Carle F. Paul, Jacek Cezary Szepietowski, Lynda J. Spelman, Thierry Passeron, Eleni Vritzali, Andrew Napoli et al. · 2024 · British Journal of Dermatology
  21. SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1
    Sin‐Yee Fung, Kam‐Leung Siu, Huayue Lin, Ching-Ping Chan, Man Lung Yeung, Dong‐Yan Jin · 2022 · Cell & Bioscience
  22. Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects
    Zhan Zhang, Qi Shen, Haocai Chang · 2022 · Frontiers in Immunology
  23. Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder
    Tsung‐Hsien Chen, Chia-Jung Chang, Peir‐Haur Hung · 2023 · International Journal of Molecular Sciences
  24. A virus‐derived microRNA targets immune response genes during SARS‐CoV‐2 infection
    Meetali Singh, Maxime Chazal, Piergiuseppe Quarato, Loan Bourdon, Christophe Malabat, Thomas Vallet, Marco Vignuzzi, Sylvie van der Werf, Sylvie Behillil, Flora Donati et al. · 2021 · EMBO Reports
  25. SARS-CoV-2 infection of sustentacular cells disrupts olfactory signaling pathways
    Abhishek Kumar Verma, Jian Hua Zheng, David Kyle Meyerholz, Stanley M. Perlman · 2022 · JCI Insight
  26. The Role of the Host Ubiquitin System in Promoting Replication of Emergent Viruses
    Karl M. Valerdi, Adam Hage, Sarah van Tol, Ricardo Rajsbaum, María I. Giraldo · 2021 · Viruses
  27. Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses
    Arinjay Banerjee, Nader El-Sayes, Patrick Budylowski, Rajesh Abraham Jacob, Daniel J. Richard, Hassaan Maan, Jennifer A. Aguiar, Wael L. L. Demian, Kaushal Baid, Michael R. D’Agostino et al. · 2021 · iScience
  28. IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation
    Sonam Popli, Sukanya Chakravarty, Shumin Fan, Anna Glanz, Siddhesh Aras, Laura E. Nagy, Ganes C. Sen, Ritu Chakravarti, Saurabh Chattopadhyay · 2022 · Proceedings of the National Academy of Sciences
  29. Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
    Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, Francesco Annunziato, Lorenzo Cosmi · 2021 · Seminars in Immunology
  30. Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight
    Chandan Bhowal, Sayak Ghosh, Debapriya Ghatak, Rudranil De · 2022 · Molecular and Cellular Biochemistry
  31. Immune evasion of SARS-CoV-2 from interferon antiviral system
    Yuan‐Qin Min, Mengzhuo Huang, Xiulian Sun, Fēi Dèng, Huálín Wáng, Yun‐Jia Ning · 2021 · Computational and Structural Biotechnology Journal
  32. Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection
    He Ren, Chaobing Ma, Haoran Peng, Bo Zhang, Lülin Zhou, Yan Ping Su, Xiaoyan Gao, Hongyan Huang · 2021 · Biology Direct
  33. Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract
    Manel Essaidi-Laziosi, Catia Alvarez, Olha Puhach, Pascale Sattonnet‐Roche, Giulia Torriani, Caroline Tapparel, Laurent Kaiser, Isabella Eckerle · 2021 · Emerging Microbes & Infections
  34. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
    Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, Behzad Aria, Behzad Hemati, Farhang Fatehi, Hamid Ghaem Maghami Farahani, Ghazaleh Javanmard, Mahsa Rezaee, John Patrick Kastelic et al. · 2021 · Frontiers in Immunology
  35. SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
    Zheng Yao Low, Nur Zawanah Zabidi, Ashley Jia Wen Yip, Ashwini Puniyamurti, Vincent T. K. Chow, Sunil Kumar Lal · 2022 · Viruses
  36. The SARS-CoV-2 papain-like protease suppresses type I interferon responses by deubiquitinating STING
    Dan Cao, Lian Duan, Bin Huang, Yuxian Xiong, Guoliang Zhang, Hao Huang · 2023 · Science Signaling
  37. Antigenic characterization of influenza and SARS-CoV-2 viruses
    Yang Wang, Cynthia Y. Tang, Xiu‐Feng Wan · 2021 · Analytical and Bioanalytical Chemistry
  38. SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication
    Yoichi Miyamoto, Yumi Itoh, Tatsuya Suzuki, Tomohisa Tanaka, Yusuke Sakai, Masaru Koido, Chiaki Hata, Caixia Wang, Mayumi Otani, Kohji Moriishi et al. · 2022 · Communications Biology
  39. SARS-CoV-2 nonstructural protein 6 triggers endoplasmic reticulum stress-induced autophagy to degrade STING1
    Pengtao Jiao, Wenhui Fan, Xiaoya Ma, Runshan Lin, Yuna Zhao, Yabo Li, He Zhang, Xiaojuan Jia, Yuhai Bi, Xiaoli Feng et al. · 2023 · Autophagy
  40. Dexamethasone may improve severe COVID-19 via ameliorating endothelial injury and inflammation: A preliminary pilot study
    Won‐Young Kim, Oh Joo Kweon, Min Jae Cha, Moon Seong Baek, Seong‐Ho Choi · 2021 · PLoS ONE
  41. Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model
    Pierre Bessière, Marine Wasniewski, Evelyne Picard Meyer, Alexandre Servat, Thomas Figueroa, Charlotte Foret, Amelia Coggon, Sandrine Lesellier, Franck Boué, Nathan Cebron et al. · 2021 · PLoS Pathogens
  42. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1
    Shilei Zhang, Jingfeng Wang, Genhong Cheng · 2021 · Proceedings of the National Academy of Sciences
  43. Host cell-intrinsic innate immune recognition of SARS-CoV-2
    Emily A. Madden, Michael S. Diamond · 2021 · Current Opinion in Virology
  44. Interferon induction, evasion, and paradoxical roles during SARS‐CoV‐2 infection*
    Carolina Chiale, Trever T. Greene, Elina I. Zúñiga · 2022 · Immunological Reviews
  45. Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2
    Manon Venet, Margarida Sá Ribeiro, Élodie Décembre, Alicia Bellomo, Garima Joshi, Célia Nuovo, Marine Villard, David Cluet, Magali Perret, Rémi Pescamona et al. · 2023 · Nature Communications
  46. TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19
    Axel Schmidt, Sophia Peters, Alexej Knaus, Hemmen Sabir, Frauke Hamsen, Carlo Maj, Julia Fazaal, Sugirthan Sivalingam, Oleksandr Savchenko, Aakash Mantri et al. · 2021 · npj Genomic Medicine
  47. Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
    Gianmarco Bellucci, Virginia Rinaldi, Maria Chiara Buscarinu, Roberta Reniè, Rachele Bigi, Giulia Pellicciari, Emanuele Morena, Carmela Romano, Antonio Marrone, Rosella Mechelli et al. · 2021 · Frontiers in Immunology
  48. Defining the balance between optimal immunity and immunopathology in influenza virus infection
    Thi H. O. Nguyen, Louise C. Rowntree, Brendon Yew Loong Chua, Ryan S. Thwaites, Katherine Kedzierska · 2024 · Nature reviews. Immunology
  49. Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
    Caroline Ruetsch-Chelli, Vesna Brglez, Marion Crémoni, Kévin Zorzi, Céline Fernandez, Sonia Boyer‐Suavet, Sylvia Benzaken, Élisa Demonchy, Karine Risso, Johan Courjon et al. · 2021 · Frontiers in Medicine
  50. Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2
    Gang Xu, Yezi Wu, Tongyang Xiao, Furong Qi, Lujie Fan, Shengyuan Zhang, Jian Zhou, Yanhua He, Xiang Gao, Hongxiang Zeng et al. · 2022 · Signal Transduction and Targeted Therapy
  51. Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators
    Daniela Ricci, Marilena Paola Etna, Fabiana Rizzo, Silvia Sandini, Martina Severa, Eliana Marina Coccia · 2021 · International Journal of Molecular Sciences
  52. N-Acetylcysteine and Hydrogen Sulfide in Coronavirus Disease 2019
    Arno R. Bourgonje, Annette K. Offringa, Larissa E. van Eijk, Amaal Eman Abdulle, Jan‐Luuk Hillebrands, Peter H. J. van der Voort, Harry van Goor, Ed. J. Van Hezik · 2021 · Antioxidants and Redox Signaling
  53. Common Genetic Variation in Humans Impacts In Vitro Susceptibility to SARS-CoV-2 Infection
    Kristina Dobrindt, Daisy A. Hoagland, Carina Seah, Bibi S. Kassim, Callan P. O’Shea, Aleta Murphy, Marina Iskhakova, Michael B. Fernando, Samuel K. Powell, P. J. Michael Deans et al. · 2021 · Stem Cell Reports
  54. Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2
    Sk. Sarif Hassan, Diksha Attrish, Shinjini Ghosh, Pabitra Pal Choudhury, Vladimir Nikolaevich Uversky, Alaa A. A. Aljabali, Kenneth H. Lundstrom, Bruce D. Uhal, Nima Rezaei, Murat Seyran et al. · 2021 · International Journal of Biological Macromolecules
  55. Off balance: Interferons in COVID-19 lung infections
    Milena Apetito Akamatsu, Júlia Tavares de Castro, Carolina Yumi Takano, Paulo Lee Ho · 2021 · EBioMedicine
  56. COVID-19 immunopathology: From acute diseases to chronic sequelae
    Mohd Arish, W. Qian, H. Narasimhan, Jie Sun · 2022 · Journal of Medical Virology
  57. Covid-19: virology, variants, and vaccines
    Megan Young, Harry Crook, Janet T. Scott, Paul Edison · 2022 · BMJ Medicine
  58. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
    Rebar N. Mohammed, Rozita Tamjidifar, Heshu Sulaiman Rahman, Ali Adili, Shadi Ghoreishizadeh, Hossein Saeedi, Lakshmi Prasanth Thangavelu, Navid Shomali, Ramin Aslaminabad, Faroogh Marofi et al. · 2022 · Cell Communication and Signaling
  59. Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation
    Hironori Nishitsuji, Satoko Iwahori, Mariko Ohmori, Kunitada Shimotohno, Takayuki Murata · 2022 · mBio
  60. Protein post-translational modification in SARS-CoV-2 and host interaction
    Nana Cheng, Mingzhu Liu, Wanting Li, BingYue Sun, Dandan Liu, Guoqing Wang, Jingwei Shi, Lisha Li · 2023 · Frontiers in Immunology
  61. Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
    Taniya Bhardwaj, Kundlik Gadhave, Shivani Krishna Kapuganti, Prateek Kumar, Z. Faidon Brotzakis, Kumar Udit Saumya, Namyashree Nayak, Ankur Kumar, Richa Joshi, Bodhidipra Mukherjee et al. · 2023 · Nature Communications
  62. Circulating Type I Interferon Levels and COVID-19 Severity: A Systematic Review and Meta-Analysis
    Rafaela Pires da Silva, João Ismael Budelon Gonçalves, Rafael Fernandes Zanin, Felipe Barreto Schuch, Ana Paula Duarte de Souza · 2021 · Frontiers in Immunology
  63. Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19
    T. Matsuyama, Steven K. Yoshinaga, Kimitaka Shibue, Tak W. Mak · 2021 · Cell Death and Differentiation
  64. Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options
    Mariem Znaidia, Caroline Demeret, Sylvie van der Werf, Anastassia V. Komarova · 2022 · Viruses
  65. Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution
    Irwin Jungreis, Chase W. Nelson, Zachary Ardern, Yaara Finkel, Nevan J. Krogan, Kei Sato, John Ziebuhr, Noam Stern‐Ginossar, Angelo Pavesi, Andrew E. Firth et al. · 2021 · Virology
  66. Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents
    Austin N. Spratt, Fabio Gallazzi, Thomas P. Quinn, Christian L. Lorson, Anders B. Sönnerborg, Kamal Deep Singh · 2021 · Expert Opinion on Therapeutic Patents
  67. ORF3a Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Inhibits Interferon-Activated Janus Kinase/Signal Transducer and Activator of Transcription Signaling via Elevating Suppressor of Cytokine Signaling 1
    Rong Wang, Xiaofeng Yang, Mingke Chang, Ziyang Xue, Weirong Wang, Liang Bai, Sihai Zhao, Enqi Liu · 2021 · Frontiers in Microbiology
  68. An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity
    Yuehui Zhang, Limin Shang, Jing Zhang, Yuchen Liu, Chaozhi Jin, Yanan Zhao, Xiaobo Lei, Wenjing Wang, Xia Xiao, Xiuyuan Zhang et al. · 2021 · Cell chemical biology
  69. Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn
    Mehdi Shahgolzari, Afagh Yavari, Yaser Arjeini, Seyed Mohammad Miri, Amirhossein Darabi, Amir Sasan Mozaffari Nejad, Mohsen Keshavarz · 2021 · Gene Reports
  70. The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
    Haiyun Yu, Fei Guan, Heather Miller, Jiahui Lei, Chaohong Liu · 2022 · Emerging Microbes & Infections
  71. SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells
    Shiv Bharadwaj, Mahendra Vikram Singh, Nikhil Kirtipal, Sang Gu Kang · 2021 · Frontiers in Molecular Biosciences
  72. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) and Spike (S) Proteins Antagonize Host Type I Interferon Response
    Qi Zhang, Zhiqiang Chen, Chenxiao Huang, Jiuyuan Sun, Minfei Xue, Tingting Feng, Wen Pan, Kezhen Wang, Jianfeng Dai · 2021 · Frontiers in Cellular and Infection Microbiology
  73. SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models
    Bettina Stolp, Marcel Stern, Ina Ambiel, Katharina Hofmann, Katharina Morath, Lara Gallucci, Mirko Cortese, Ralf F. W. Bartenschlager, Alessia Ruggieri, Frederik Graw et al. · 2022 · Cell Reports
  74. The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
    Esther Moga, Elionor Lynton‐Pons, Peré Domingo · 2022 · Frontiers in Immunology
  75. SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3
    Craig Schindewolf, Kumari G. Lokugamage, Michelle N. Vu, Bryan A. Johnson, Dionna Scharton, Jessica A. Plante, Birte Kalveram, Patricia A. Crocquet-Valdes, Stephanea L. Sotcheff, Elizabeth A. Jaworski et al. · 2023 · Journal of Virology
  76. High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity
    Ryan Choi, Mowei Zhou, Roger Shek, Jesse Wilson, Logan M. Tillery, Justin K. Craig, Indraneel A. Salukhe, Sarah E. Hickson, Neeraj Kumar, Rhema M. James et al. · 2021 · PLoS ONE
  77. COVID-19, the first pandemic in the post-genomic era
    Lucy van Dorp, Charlotte J. Houldcroft, Damien Richard, François Balloux · 2021 · Current Opinion in Virology
  78. A C-terminal glutamine recognition mechanism revealed by E3 ligase TRIM7 structures
    Xiao Liang, Jun Hai Xiao, Xuzichao Li, Yujie Liu, Yao Ping Lu, Yanan Wen, Zexing Li, Xing Che, Yongjian Ma, Xingyan Zhang et al. · 2022 · Nature Chemical Biology
  79. Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies
    Hai Trong Nguyen, Darryl Falzarano, Volker Gerdts, Qiang Liu · 2021 · Journal of Virology
  80. Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions
    Mai Mohamed Abdelmoaty, Pravin Yeapuri, Jatin Machhi, Katherine E. Olson, Farah Shahjin, Vikas S. Kumar, You Zhou, Jingjing Liang, Kabita Pandey, Arpan Acharya et al. · 2021 · Frontiers in Immunology
  81. SARS-CoV-2 Spike Antagonizes Innate Antiviral Immunity by Targeting Interferon Regulatory Factor 3
    Raul Sousa Freitas, Tyler F. Crum, Kislay Parvatiyar · 2022 · Frontiers in Cellular and Infection Microbiology
  82. SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog
    Jiyao Chen, Zhuang Li, Jiahui Guo, Shangen Xu, Junwei Zhou, Qian Chen, Xue Tong, Dang Wang, Guiqing Peng, Liurong Fang et al. · 2022 · Journal of Virology
  83. COVID-19: systemic pathology and its implications for therapy
    Qi Shen, Jie Li, Zhan Zhang, Shuang Guo, Qiuhong Wang, Xiaorui An, Haocai Chang · 2021 · International Journal of Biological Sciences
  84. Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue
    Guoli Shi, Tiansheng Li, Kin Kui Lai, Reed F. Johnson, Jonathan Wilson Yewdell, Alex A. Compton · 2024 · Nature Communications
  85. I(nsp1)ecting SARS-CoV-2–ribosome interactions
    Matthieu Simeoni, Théo Cavinato, Daniel Rodríguez, David Gatfield · 2021 · Communications Biology
  86. An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination
    Bülent Kantarcıoğlu, Omer Iqbal, Jeanine M. Walenga, Bruce Lewis, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio A. Lievano, Alfonso Javier Tafur, Eduardo Ramacciotti et al. · 2021 · Clinical and Applied Thrombosis/Hemostasis
  87. A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder
    Aziz Rodan Sarohan, Murat Kızıl, Ahmet Çağkan İnkaya, Shokhan Osman Mahmud, Muhammad Akram, Osman Çen · 2021 · Cellular Signalling
  88. Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions
    Eric Allan Meyerowitz, Pritha Sen, Sara R. Schoenfeld, Tomas G. Neilan, Matthew J. Frigault, John H. Stone, Arthur Y. Kim, Michael K. Mansour · 2020 · Clinical Infectious Diseases
  89. A Comparative Analysis of Coronavirus Nucleocapsid (N) Proteins Reveals the SADS-CoV N Protein Antagonizes IFN-β Production by Inducing Ubiquitination of RIG-I
    Yan Liu, Qizhang Liang, Wan Lu, Yong‐Le Yang, Ruiai Chen, Yao‐Wei Huang, Bin Wang · 2021 · Frontiers in Immunology
  90. Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation
    Joseph Yunis, Kirsty Renfree Short, Di Yu · 2023 · Trends in Microbiology
  91. Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2
    Hongjie Xia, Pei‐Yong Shi · 2020 · Journal of Interferon & Cytokine Research
  92. ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions
    Daniel J. Rawle, Thuy T. Le, Troy D. Dumenil, Kexin Yan, Bing Tang, Wilson Nguyen, Daniel Watterson, Naphak Modhiran, Jody Hobson‐Peters, Cameron Bishop et al. · 2021 · PLoS Pathogens
  93. Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity
    Deanna M. Santer, Daniel Li, Yanal Ghosheh, Muhammad Atif Zahoor, Dhanvi Prajapati, Bettina E. Hansen, D. Lorne Tyrrell, Jordan J. Feld, Adam J. Gehring · 2022 · Nature Communications
  94. Type I Interferons in COVID-19 Pathogenesis
    Enrico Palermo, Daniele Di Carlo, Marco Sgarbanti, John B. Hiscott · 2021 · Biology
  95. All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses
    Alessandra C. Setaro, Marta Maria Gaglia · 2021 · Current Research in Virological Science
  96. SARS-CoV-2 genetic variations associated with COVID-19 pathogenicity
    Pakorn Aiewsakun, Patrawee Nilplub, Patompon Wongtrakoongate, Suradej Hongeng, Arunee Thitithanyanont · 2021 · Microbial Genomics
  97. Immunology of COVID ‐19
    Harald Brüssow · 2020 · Environmental Microbiology
  98. Generation and Functional Analysis of Defective Viral Genomes during SARS-CoV-2 Infection
    Terry Zhou, Nora J. Gilliam, Sizhen Li, Simone Spandau, Raven M. Osborn, Sarah Connor, Christopher Anderson, Thomas J. Mariani, Juilee Thakar, Stephen Dewhurst et al. · 2023 · mBio
  99. Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease
    Charles E. Samuel · 2023 · Journal of Biological Chemistry
  100. Universal features of Nsp1-mediated translational shutdown by coronaviruses
    Schubert, Katharina, Karousis, Evangelos D., Ban, Ivo, Lapointe, Christopher P., Leibundgut, Marc, Bäumlin, Emilie, Kummerant, Eric, Scaiola, Alain, Schönhut, Tanja, Ziegelmüller, Jana et al. · 2023 · Molecular Cell